ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3087% above fair value
$178.48+1.57 (+0.89%)
Close on Nov 18, 2026Market cap $4.46BP/E 148.7Yield –
ICU Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ICU Medical's free cash flow for the twelve months ending Jun 30, 2026 was $152.83M, up 152.5% year over year. For fiscal 2025 it was $91.80M, down 26.4% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $199.00M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $91.80M | -26.4% |
| FY2024 | Dec 31, 2024 | $124.66M | +51.5% |
| FY2023 | Dec 31, 2023 | $82.31M | – |
| FY2022 | Dec 31, 2022 | -$152.44M | -176.6% |
| FY2021 | Dec 31, 2021 | $199.00M | +52.2% |
| FY2020 | Dec 31, 2020 | $130.75M | +2738.6% |
| FY2019 | Dec 31, 2019 | $4.61M | -93.2% |
| FY2018 | Dec 31, 2018 | $67.50M | -15.6% |
| FY2017 | Dec 31, 2017 | $79.94M | +20.1% |
| FY2016 | Dec 31, 2016 | $66.58M | +30.0% |
| FY2015 | Dec 31, 2015 | $51.21M | +3.0% |
| FY2014 | Dec 31, 2014 | $49.74M | +5.1% |
| FY2013 | Dec 31, 2013 | $47.31M | +0.4% |
| FY2012 | Dec 31, 2012 | $47.11M | -3.2% |
| FY2011 | Dec 31, 2011 | $48.66M | +390.4% |
| FY2010 | Dec 31, 2010 | $9.92M | -71.2% |
| FY2009 | Dec 31, 2009 | $34.45M | +81.6% |
| FY2008 | Dec 31, 2008 | $18.97M | +6.2% |
| FY2007 | Dec 31, 2007 | $17.87M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $61.64M | – |
| Q1 FY2026 | Mar 31, 2026 | $27.61M | -24.8% |
| Q4 FY2025 | Dec 31, 2025 | $35.95M | +123.2% |
| Q3 FY2025 | Sep 30, 2025 | $27.63M | +70.7% |
| Q2 FY2025 | Jun 30, 2025 | -$8.49M | -113.6% |
| Q1 FY2025 | Mar 31, 2025 | $36.71M | +22.9% |
| Q4 FY2024 | Dec 31, 2024 | $16.11M | -73.7% |
| Q3 FY2024 | Sep 30, 2024 | $16.19M | +18.2% |
| Q2 FY2024 | Jun 30, 2024 | $62.49M | – |
| Q1 FY2024 | Mar 31, 2024 | $29.88M | +10.5% |
| Q4 FY2023 | Dec 31, 2023 | $61.33M | – |
| Q3 FY2023 | Sep 30, 2023 | $13.69M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.76M | – |
| Q1 FY2023 | Mar 31, 2023 | $27.04M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.31M | -138.5% |
| Q3 FY2022 | Sep 30, 2022 | -$18.37M | -129.6% |
| Q2 FY2022 | Jun 30, 2022 | -$85.82M | -319.5% |
| Q1 FY2022 | Mar 31, 2022 | -$24.95M | -166.9% |
| Q4 FY2021 | Dec 31, 2021 | $60.54M | +23.9% |
| Q3 FY2021 | Sep 30, 2021 | $62.06M | +20.2% |
| Q2 FY2021 | Jun 30, 2021 | $39.10M | +141.8% |
| Q1 FY2021 | Mar 31, 2021 | $37.29M | +165.3% |
| Q4 FY2020 | Dec 31, 2020 | $48.88M | +97.1% |
| Q3 FY2020 | Sep 30, 2020 | $51.64M | +96.6% |
| Q2 FY2020 | Jun 30, 2020 | $16.17M | +403.2% |
| Q1 FY2020 | Mar 31, 2020 | $14.06M | – |
| Q4 FY2019 | Dec 31, 2019 | $24.81M | -23.1% |
| Q3 FY2019 | Sep 30, 2019 | $26.27M | +11.2% |
| Q2 FY2019 | Jun 30, 2019 | $3.21M | -94.5% |
| Q1 FY2019 | Mar 31, 2019 | -$49.68M | – |
| Q4 FY2018 | Dec 31, 2018 | $32.27M | -47.8% |
| Q3 FY2018 | Sep 30, 2018 | $23.63M | -68.2% |
| Q2 FY2018 | Jun 30, 2018 | $58.87M | +59.4% |
| Q1 FY2018 | Mar 31, 2018 | -$47.28M | – |
| Q4 FY2017 | Dec 31, 2017 | $61.77M | +379.2% |
| Q3 FY2017 | Sep 30, 2017 | $74.24M | +253.1% |
| Q2 FY2017 | Jun 30, 2017 | $36.94M | – |
| Q1 FY2017 | Mar 31, 2017 | -$93.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.89M | – |
| Q3 FY2016 | Sep 30, 2016 | $21.03M | – |
See a number that looks wrong?